Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | |
| Sales | 4,400 |
| Cost of Goods | 4,680 |
| Gross Profit | -280 |
| Operating Expenses | 5,430 |
| Operating Income | -5,030 |
| Interest Expense | 110 |
| Other Income | 530 |
| Pre-tax Income | -4,610 |
| Net Income Continuous | -4,615 |
| Net Income | $-4,610 |
| EPS Basic Total Ops | -1.07 |
| EPS Basic Continuous Ops | -1.04 |
| EPS Diluted Total Ops | -1.07 |
| EPS Diluted Continuous Ops | -1.04 |
| EBITDA(a) | $-4,330 |